Herbal medicine and cardiovascular diseases

Therapeutische Umschau

Volumn 59, Issue 6, 2002, Pages 301-306

  Zbinden, S ^a   Seiler, Ch ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CRATAEGUS EXTRACT; FLAVONOID; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; TERPENE DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR; PLANT EXTRACT;

ACTION POTENTIAL; ANTIARRHYTHMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMICAL COMPOSITION; CHOLESTEROL DIET; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HEART FAILURE; HERBAL MEDICINE; HUMAN; INOTROPISM; MULTIINFARCT DEMENTIA; PERIPHERAL VASCULAR DISEASE; REFRACTORY PERIOD; THROMBOCYTE AGGREGATION INHIBITION; CLINICAL TRIAL; DOSE RESPONSE; PHYTOTHERAPY; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 2242459341     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.59.6.301     Document Type: Article

References (30)

1. Stinkender Gingko
2. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761)
3. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion
4. Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials
5. Behandlung der PAVK mit Ginkgo-biloba-Extrakt (GBE) oder Pentoxifyllin
6. Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery
7. Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications
8. Clinical improvement of memory and other cognitive functions by Ginkgo biloba: Review of relevant literature
9. ...Or garlic
10. Garlic powder for hyperlipidemia: Analysis of recent negative results
11. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations
12. Historical perspective on garlic and cardiovascular disease
13. Effect of an odor-modified garlic preparation on blood lipids
14. A double-blind crossover study in moderately hypercholesterolaemia men that compared the effect of aged garlic extract and placebo administration on blood lipids
15. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate
16. The antiatherosclerotic effect of Allium sativum
17. German garlic study under scrutiny
18. Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects
19. Garlic shows promise for improving some cardiovascular risk factors
20. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials
21. Clinical outcomes in statin treatment trials: A meta-analysis
22. Effects of garlic coated tablets in peripheral arterial occlusive disease
23. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors
24. Klinische Untersuchungen mit einem Knoblauch-Lezithin-Präparat
25. Phytogenic drugs in heart diseases exemplified by Crataegus
26. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently
27. Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes
28. Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study
29. Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)
30. Survival and prognosis: Investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE) - Rationale, study design and study protocol